Exchange Capital Management, Inc. Danaher Corp Transaction History

Exchange Capital Management, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 29, 2020	SELL	$133.47 - $153.48 $482,360 - $554,676	-3,614 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$135.4 - $146.47 $7,176 - $7,762	53 Added 1.49%	3,614 $522,000
Q2 2019 Jul 22, 2019	SELL	$124.88 - $143.73 $11,988 - $13,798	-96 Reduced 2.63%	3,561 $509,000
Q1 2019 Apr 17, 2019	SELL	$97.62 - $132.29 $25,185 - $34,130	-258 Reduced 6.59%	3,657 $483,000
Q3 2018 Oct 25, 2018	SELL	$98.13 - $108.9 $84,293 - $93,545	-859 Reduced 17.99%	3,915 $425,000
Q2 2018 Aug 01, 2018	SELL	$96.1 - $103.24 $2,979 - $3,200	-31 Reduced 0.65%	4,774 $471,000
Q1 2018 May 03, 2018	SELL	$92.16 - $103.8 $431,585 - $486,095	-4,683 Reduced 49.36%	4,805 $470,000
Q4 2017 May 07, 2018	BUY	$85.26 - $94.62 $34,530 - $38,321	405 Added 4.46%	9,488 $881,000
Q4 2017 Feb 05, 2018	SELL	$85.26 - $94.62 $66,843 - $74,182	-784 Reduced 7.95%	9,083 $843,000
Q3 2017 Nov 02, 2017	BUY	$79.29 - $88.45 $782,354 - $872,736	9,867	9,867 $846,000

2,511

542M

7.07M

4.55M

Ticker DHR
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 727,963,008
Market Cap $175B
Description
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The company operates through three segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automati...

Get notified when there are updates to the investment portfolio of Exchange Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Exchange Capital Management, Inc. with notifications on news.